New to Meducation?
Sign up
Already signed up? Log In
view moderators

AtrialFibrillation

Category

Preview
0
8

Swedish study shows Thumb-ECG self monitoring by stroke patients cuts risks of silent atrial fibrillation

A new clinical study published in Europace, shows that regular screening using a handheld-ECG device on 75-year-old stroke patients for detecting silent atrial fibrillation (AF) is both...  
medicalnewstoday.com
over 6 years ago
Preview
0
18

The Stiell Sessions 2 Update in Atrial Fibrillation | EM Cases

Dr. Ian Stiell of Ottawa Research Institute discusses Atrial Fibrillation on EM Cases podcast including the Canadian Cardiovascular Socciety Guidelines 2014  
emergencymedicinecases.com
over 6 years ago
Preview
0
4

Treating Sleep Apnea May Help Those With Heart Rhythm Disorder - MedicineNet

People with both atrial fibrillation and obstructive sleep apnea are less likely to have a recurrence of the heart rhythm disorder if they use continuous positive airway pressure (CPAP) therapy, a new report says.  
medicinenet.com
over 6 years ago
Preview
0
4

Treating Sleep Apnea May Help Those With Heart Rhythm Disorder

Researchers recommend sleep disorder screening for patients with atrial fibrillation  
webmd.com
over 6 years ago
Preview
0
3

Atrial fibrillation recurrence lower with sleep apnea treatment

The use of continuous positive airway pressure was associated with a significant reduction in the recurrence of atrial fibrillation in patients with obstructive sleep apnea, according to an analysis of data from past research published today in the Journal of the American College of Cardiology: Clinical Electrophysiology.  
eurekalert.org
over 6 years ago
Preview
0
3

Pharmacists Key to Whether Patients Take Blood Thinners - MedicineNet

Millions of older Americans are prescribed a blood thinner to help reduce the stroke risks associated with a dangerous irregular heart beat known as atrial fibrillation.  
medicinenet.com
over 6 years ago
Preview
0
5

Blood Thinners Overprescribed for Low-Risk Irregular Heartbeat: Study - MedicineNet

As many as one-quarter of people with atrial fibrillation who have a low risk of stroke are given blood-thinning drugs they likely don't need, a new study contends .  
medicinenet.com
over 6 years ago
Preview
0
5

First use of new ablation catheter in US offers improved atrial fibrillation treatment

Dr. Daniel Melby, an investigator at the Minneapolis Heart Institute Foundation, performed the first atrial fibrillation ablation in the US using Biosense Webster's new THERMOCOOL SMARTTOUCH SF contact force sensing catheter as part of an FDA regulated safety trial. 'Contact force sensing combined with the more efficient irrigation design of this catheter may allow for a more effective ablation pattern while potentially reducing risk of thrombus formation and improving outcomes,' said Dr. Melby.  
eurekalert.org
over 6 years ago
Preview
0
0

New AF guidelines from AHA/ACC |

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary J Am Coll Cardiol. 2014;64(21):2246-2280 Free full text  
resus.me
over 6 years ago
Preview
0
13

Safety of new oral anticoagulants

Two linked papers (doi:10.1136/bmj.h1857, doi:10.1136/bmj.h1585) report additional evidence on the risks of gastrointestinal bleeding among patients taking the novel oral anticoagulants dabigatran and rivaroxaban.1 2 From a database of more than 100 million US adults, Abraham and colleagues identified almost 220 000 new users of dabigatran, rivaroxaban, or warfarin between November 2010 and September 2013.1 In their comparison of propensity score matched patients, the risk of gastrointestinal bleeding increased significantly with age for both new oral anticoagulants, relative to warfarin. By age 75, the risk of gastrointestinal bleeding associated with rivaroxaban exceeded that with warfarin, for patients with or without atrial fibrillation. Among patients taking dabigatran, the association between older age and higher risk was confined to those with atrial fibrillation, although the data included very few patients without atrial fibrillation taking this drug.  
feeds.bmj.com
over 6 years ago
Preview
0
15

Safety of new oral anticoagulants

Two linked papers (doi:10.1136/bmj.h1857, doi:10.1136/bmj.h1585) report additional evidence on the risks of gastrointestinal bleeding among patients taking the novel oral anticoagulants dabigatran and rivaroxaban.1 2 From a database of more than 100 million US adults, Abraham and colleagues identified almost 220 000 new users of dabigatran, rivaroxaban, or warfarin between November 2010 and September 2013.1 In their comparison of propensity score matched patients, the risk of gastrointestinal bleeding increased significantly with age for both new oral anticoagulants, relative to warfarin. By age 75, the risk of gastrointestinal bleeding associated with rivaroxaban exceeded that with warfarin, for patients with or without atrial fibrillation. Among patients taking dabigatran, the association between older age and higher risk was confined to those with atrial fibrillation, although the data included very few patients without atrial fibrillation taking this drug.  
feeds.bmj.com
over 6 years ago
Www.bmj
0
24

Safety of new oral anticoagulants

Two linked papers (doi:10.1136/bmj.h1857, doi:10.1136/bmj.h1585) report additional evidence on the risks of gastrointestinal bleeding among patients taking the novel oral anticoagulants dabigatran and rivaroxaban.1 2 From a database of more than 100 million US adults, Abraham and colleagues identified almost 220 000 new users of dabigatran, rivaroxaban, or warfarin between November 2010 and September 2013.1 In their comparison of propensity score matched patients, the risk of gastrointestinal bleeding increased significantly with age for both new oral anticoagulants, relative to warfarin. By age 75, the risk of gastrointestinal bleeding associated with rivaroxaban exceeded that with warfarin, for patients with or without atrial fibrillation. Among patients taking dabigatran, the association between older age and higher risk was confined to those with atrial fibrillation, although the data included very few patients without atrial fibrillation taking this drug.  
feeds.bmj.com
over 6 years ago
Static.www.bmj
0
13

Spontaneous hypokalaemia in a man with treated hypertension

An 80 year old man with a history of hypertension, stage 3 chronic kidney disease, and paroxysmal atrial fibrillation presented feeling generally unwell and lethargic. He was taking amiodarone 200 mg, bisoprolol 10 mg, amlodipine 10 mg, and lisinopril 20 mg a day. He did not have a fever and he was haemodynamically stable. His blood pressure was controlled (132/84 mm Hg). Physical examination was unremarkable. Blood tests showed hypokalaemia (1.9 mmol/L, reference range 3.5-5.0), hypomagnesaemia (0.58 mmol/L, 0.6-1.2), and metabolic alkalosis (35 mmol/L, 20-32). His symptoms resolved after electrolyte replacement and he was discharged home.  
feeds.bmj.com
over 6 years ago